CSRxP Praises FDA For Finalizing Guidance On Interchangeable Biologics
Clearer Guidelines Will Increase Choice and Help Lower Prices Washington… Read More
Clearer Guidelines Will Increase Choice and Help Lower Prices Washington… Read More
Washington, D.C. – The House Energy & Commerce Subcommittee on Health… Read More
Encourages House Leaders To Keep The Momentum Going Following Passage Of First… Read More
Vote On Orange And Purple Book Bills Should Mark Beginning Of A Series Of… Read More
Greater List Price Transparency Will Help Hold Big Pharma Accountable … Read More
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
Encourages Judiciary Committee To Hold Drug Makers Accountable… Read More
Nonpartisan Analysis Projects HHS Proposal A $187 Billion Budget-Buster That… Read More
Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge… Read More
GSK Completes The Sweep: Joins Fellow Drug Maker Giants In Beating Q1 Profit… Read More
Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge… Read More
Three more earnings reports from drug makers show Big Pharma is doing just… Read More